Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
603
All time
Disclosed funding
$28.7B
480 disclosed amounts
Median round
$17M
Of disclosed amounts
603 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
Revascular Bio Co., Ltd.Biotech · JapanCompany profile

Revascular Bio develops cell therapies using vascular endothelial stem cells.

Revascular Bio develops cell therapies using vascular endothelial stem cells.

UndisclosedFY2025 Go-Tech research and development grantUndisclosedBiotechJapanInvestors
Undisclosed
Intero BiosystemsBiotech · United StatesCompany profile

Human intestinal organoids for preclinical research and testing.

Human intestinal organoids for preclinical research and testing.

$2MPre-seedBiotechUnited StatesInvestors
Aoxi BiopharmaceuticalBiotech · ChinaCompany profile

Develops antibody–oligonucleotide conjugates to deliver nucleic-acid medicines to disease-related cells.

Develops antibody–oligonucleotide conjugates to deliver nucleic-acid medicines to disease-related cells.

CN¥12MGrant-to-equity project support disclosed May 2025UndisclosedBiotechChinaInvestors
Undisclosed
OmnioBiotech · SwedenCompany profile

Omnio develops a plasminogen-based biologic for chronic wounds, initially diabetic foot ulcers.

Omnio develops a plasminogen-based biologic for chronic wounds, initially diabetic foot ulcers.

~€4.3MFunding roundUndisclosedBiotechSwedenInvestors
Undisclosed
VitroscopeBiotech · NorwayCompany profile

Vitroscope builds laboratory platforms that keep living tissue under controlled fluid flow for drug discovery and disease research.

Vitroscope builds laboratory platforms that keep living tissue under controlled fluid flow for drug discovery and disease research.

≤NOK 16Mvitro.scale grant approvalUndisclosedBiotechNorwayInvestors
Latigo BiotherapeuticsBiotech · United StatesCompany profile

Latigo Biotherapeutics develops non-opioid pain medicines that target peripheral pain signaling.

Latigo Biotherapeutics develops non-opioid pain medicines that target peripheral pain signaling.

$150MSeries BBiotechUnited StatesInvestors
Revascular Bio Co., Ltd.Biotech · JapanCompany profile

Revascular Bio develops cell therapies using vascular endothelial stem cells.

Revascular Bio develops cell therapies using vascular endothelial stem cells.

¥3MFY2024 second MU-TECH research grantUndisclosedBiotechJapanInvestors
molmir Inc.Biotech · JapanCompany profile

molmir develops ways to observe molecular dynamics and uses that knowledge to identify new targets for medicines.

molmir develops ways to observe molecular dynamics and uses that knowledge to identify new targets for medicines.

¥3MFY2024 second MU-TECH research grantUndisclosedBiotechJapanInvestors
Arctic TherapeuticsBiotech · IcelandCompany profile

Arctic Therapeutics develops treatments for neurological, autoimmune and inflammatory skin diseases using insights from human genetics.

Arctic Therapeutics develops treatments for neurological, autoimmune and inflammatory skin diseases using insights from human genetics.

€26.5MSeries ABiotechIcelandInvestors
OMGene.AIAI · IsraelCompany profile

Behavioral intelligence combining AI, genomic research and human data to model decisions and simulate outcomes.

Behavioral intelligence combining AI, genomic research and human data to model decisions and simulate outcomes.

$3MInfinity Group research fundingUndisclosedBiotech, AIIsraelInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    RA Capital Management

    Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics

    27rounds
    6led
  2. 2
    Eli Lilly and Company

    Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.

    16rounds
    0led
  3. 3
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    16rounds
    1led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    16rounds
    1led
  5. 5
    OrbiMed

    Dren Bio, Star Therapeutics, Leal Therapeutics

    12rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic